Partner, Domain Associates
Brian Dovey is Co-Dean of the Kauffman Fellows Program and has been a Partner of Domain Associates since 1988. Since joining Domain, he has served as Chairman of Athena Neurosciences, Creative BioMolecules, and Univax Biologics and on the Board of Directors of some 30+ additional companies, including Align Technology, British Biotech, Cardiac Science, Connetics, Geron, Ista Pharmaceuticals, NABI, Neose, ReSound, Trimeris, U.S. Bioscience, and Vivus.
Prior to Domain, Mr. Dovey spent six years at Rorer Group (now Sanofi Aventis as a result of subsequent mergers). As President of Rorer from 1986 to 1988, he was the primary architect of this Fortune 500 company’s strategic shift to pharmaceuticals that resulted in a doubling of annual sales to approximately $1 billion. Previously, Mr. Dovey was President of Survival Technology, a start-up medical products company whose sales growth placed it in the top ten of the Inc. 100. He has also held management positions with Howmedica, Howmet Corporation, and New York Telephone.
Mr. Dovey has served as both President and Chairman of the National Venture Capital Association. He is Chair of the Wistar Institute, a leader in preclinical bio-medical research in the non-profit sector. He is Trustee Emeritus of Germantown Academy and a former Trustee of the University of Pennsylvania School of Nursing. He is also a former Board Member of the Advanced Medical Technology Association and the Consumer Healthcare Products Association and served on the Board of Trustees of the Burnham Institute.